SYRE Insider Transactions — Page 2
139 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 101–139; provenance stays internal.
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| Schuchart Aaron | Chief Business Officer | 2018-09-27 | Sale | 100.0 | $9.55 |
| Quinn Anthony G. | President & CEO | 2018-08-15 | Purchase | 994.0 | $9.13 |
| NOVARTIS AG | TenPercentOwner | 2018-05-11 | Sale | 19,550.0 | $10.06 |
| Novartis Bioventures Ltd | TenPercentOwner | 2018-05-11 | Sale | 19,550.0 | $10.06 |
| NOVARTIS AG | TenPercentOwner | 2018-05-10 | Sale | 22,725.0 | $10.13 |
| Novartis Bioventures Ltd | TenPercentOwner | 2018-05-10 | Sale | 22,725.0 | $10.13 |
| NOVARTIS AG | TenPercentOwner | 2018-05-09 | Sale | 51,230.0 | $10.11 |
| Novartis Bioventures Ltd | TenPercentOwner | 2018-05-09 | Sale | 51,230.0 | $10.11 |
| NOVARTIS AG | TenPercentOwner | 2018-05-08 | Sale | 26,557.0 | $10.03 |
| Novartis Bioventures Ltd | TenPercentOwner | 2018-05-08 | Sale | 26,557.0 | $10.03 |
| NOVARTIS AG | TenPercentOwner | 2018-05-07 | Sale | 15,548.0 | $10.11 |
| Novartis Bioventures Ltd | TenPercentOwner | 2018-05-07 | Sale | 15,548.0 | $10.11 |
| Quinn Anthony G. | President & CEO | 2018-02-15 | Purchase | 2,000.0 | $6.02 |
| Quinn Anthony G. | Interim CEO | 2017-12-08 | Purchase | 600.0 | $5.07 |
| Quinn Anthony G. | Interim CEO | 2017-12-07 | Purchase | 2,800.0 | $4.99 |
| Quinn Anthony G. | Interim CEO | 2017-12-06 | Purchase | 4,888.0 | $4.92 |
| York Charles N II | Chief Financial Officer and VP | 2017-12-05 | Purchase | 10,241.0 | $4.76 |
| Quinn Anthony G. | Director | 2017-12-05 | Purchase | 5,065.0 | $4.93 |
| York Charles N II | Chief Financial Officer and VP | 2017-12-04 | Purchase | 3,259.0 | $4.97 |
| Quinn Anthony G. | Director | 2017-12-04 | Purchase | 7,956.0 | $4.98 |
| York Charles N II | Chief Financial Officer and VP | 2017-12-01 | Purchase | 6,500.0 | $4.59 |
| Quinn Anthony G. | Director | 2017-12-01 | Purchase | 4,100.0 | $4.53 |
| York Charles N II | Chief Financial Officer and VP | 2017-08-15 | Purchase | 1,959.0 | $2.52 |
| ISALY SAMUEL D | TenPercentOwner | 2017-02-21 | Purchase | 7,000.0 | $5.36 |
| ORBIMED ADVISORS LLC | TenPercentOwner | 2017-02-21 | Purchase | 7,000.0 | $5.36 |
| OrbiMed Capital GP V LLC | TenPercentOwner | 2017-02-21 | Purchase | 7,000.0 | $5.36 |
| ISALY SAMUEL D | TenPercentOwner | 2017-02-17 | Purchase | 71,800.0 | $5.19 |
| ORBIMED ADVISORS LLC | TenPercentOwner | 2017-02-17 | Purchase | 71,800.0 | $5.19 |
| OrbiMed Capital GP V LLC | TenPercentOwner | 2017-02-17 | Purchase | 71,800.0 | $5.19 |
| ISALY SAMUEL D | TenPercentOwner | 2017-02-16 | Purchase | 30,500.0 | $5.04 |
| ORBIMED ADVISORS LLC | TenPercentOwner | 2017-02-16 | Purchase | 30,500.0 | $5.04 |
| OrbiMed Capital GP V LLC | TenPercentOwner | 2017-02-16 | Purchase | 30,500.0 | $5.04 |
| York Charles N II | Chief Financial Officer and VP | 2017-02-15 | Purchase | 2,000.0 | $4.28 |
| York Charles N II | Chief Financial Officer and VP | 2016-08-15 | Purchase | 2,000.0 | $3.99 |
| LILLY ELI & CO | TenPercentOwner | 2016-04-12 | Purchase | 500,000.0 | $10.0 |
| Quinn Anthony | Director | 2016-04-12 | Purchase | 10,000.0 | $10.0 |
| NOVARTIS AG | TenPercentOwner | 2016-04-12 | Purchase | 300,000.0 | $10.0 |
| Novartis Bioventures Ltd | TenPercentOwner | 2016-04-12 | Purchase | 300,000.0 | $10.0 |
| Cox Russell J. | Director | 2016-04-12 | Purchase | 7,000.0 | $10.0 |